Thorne to Join P&G Health Care Portfolio
Acquisition strengthens P&G’s ability to serve growing consumer demand for science-backed, practitioner-trusted wellness solutions
Today, P&G shared its intention to acquire Thorne, a leading science-driven wellness company known for its high-quality supplements and personalized health solutions backed by health care practitioners
The acquisition would expand P&G Health Care’s ability to meet growing consumer interest in self-care, prevention and personalized wellness — areas where trusted science, product quality and practitioner credibility increasingly matter
“Thorne has built a highly trusted brand at the forefront of personalized health,” said Paul Gama, Chief Executive Officer, Health Care. “Together, we see an opportunity to bring Thorne’s science-backed wellness solutions to more consumers while continuing to build on the quality, credibility and innovation that have made the brand successful.”
Thorne has earned a strong reputation with consumers, health care practitioners and professional partners through its commitment to scientific rigor, product quality and innovation. These strengths make Thorne a complementary fit with P&G’s Health Care portfolio and our commitment to helping consumers improve everyday health and well-being
The transaction is subject to customary closing conditions, including regulatory approvals. Closing is expected later in calendar year 2026
Learn more about Thorne here
Read the news release for more information.
Forward-looking statements in this post are based on current assumptions and subject to risks and uncertainties that could cause actual results to differ materially. A discussion of these risks and uncertainties is included in P&G’s most recent Form 10-K. We undertake no obligation to update these statements, except as required by law
